27. August 2017
Pharmaceutical dosage forms address diverse key components but satisfying unmet patient needs to enhance patient adherence is a major challenge. The desired design of patient-centered drug products should be based on characteristics of various components, such as patients, disease, routes of administration, drug delivery technologies and active pharmaceutical ingredients.
14. March 2017
March 14, 2017 12:00 AM Eastern Daylight Time BOSTON & MUMBAI, India--(BUSINESS WIRE)--TA Associates, a leading global growth private equity firm, today announced it has completed an investment in Ideal Cures Private Limited, a supplier of ready-to-use coating products and excipients for tablets and capsules to the pharmaceutical and allied industries. Financial terms of the transaction were not disclosed. Founded in 1999 in India, Ideal Cures’ products are used to provide aesthetic...
15. December 2016
Introduction Talc has been traditionally used as an anti-tack agent in various immediate release and enteric coating formulations. However, it is subject to sedimentation and may cause system instability. Sedimentation of talc can lead to process concerns such as gun clogging which may lead to frequent process interruptions. Objective To determine the feasibility of formulating a ready mixed immediate release coating system containing polymer, plasticizer, and a non-talc anti-adherent agent....
12. December 2016
Introduction It is common practice within the pharmaceutical industry to enhance the aesthetic appearance of dosage forms by using suitably colored film coatings (1). Colored coatings increase patient acceptability and compliance, improve safety via easy identification and differentiation and may reduce degradation via increased opacity to light. Indigo Carmine (FD & C Blue #2) or Indigotine is approved in US and European Markets to be used as a colorant in oral and topical preparations. It...
17. November 2016
MUMBAI, India--(BUSINESS WIRE)--Ideal Cures Private Limited is pleased to announce the addition of a fourth manufacturing location at Sikkim in India for supply of its best-in-class products for not only the pharmaceutical and allied industries in the region, but also its expanding customer base globally. Ideal Cures, the first film coating company in the world with all its plants EXCiPACT™ certified, is all set to bring its latest facility, which is presently under construction, on line for...
26. September 2016
Galenicum and Ideal Cures are pleased to invite you to the conference: INSTACOAT 4G* - Innovation in film coating technology from Ideal Cures Pvt. Ltd. "The new ready-to-use film coating system for solid dosage forms, the most advanced on the market, developed by Ideal Cures Pvt. Ltd." The conference will be led by Dario Luini, EMEA & US Sales and Technical Manager for Ideal Cures, which is represented by Galenicum. It will take plac in Barcelona's CPhI 2016 on the 5th of October, at 12:30,...
14. June 2016
June 14, 2016 09:04 AM Eastern Daylight Time MUMBAI, India--(BUSINESS WIRE)--Ideal Cures Private Limited, announces the appointment of Mr. Mike Easterbrook as Chief Technical Officer, a stalwart in the Film Coating technical arena with more than 40 years of experience. His addition strengthens the existing team of professionals at Ideal Cures and its aggressive strategy to support its international customer base with best-in-class products, technologies, services and sales. Read full article
07. March 2016
Ideal Cures has recently announced the opening of its representative office in the US. Dr Kamlesh Oza as the new President – Global Business Development will take charge of expanding the company’s global reach. Sanjiv Das finds out more on his vision for the company in an interview More
04. May 2015
EXCiPACT asbl is delighted to announce that Ideal Cures Pvt.Ltd. of India has recently been awarded two EXCiPACT™ Certificates from SGS France, one of EXCIPACT’s internationally-recognised Certification Bodies. http://www.excipact.org/publication-items/28-apr-2015-ideal-cures-pvt-ltd-is-the-first-indian-company-to-receive-excipact-certification-as-pharmaceutical-excipient-suppliers/